Jane Street’s Calithera Biosciences, Inc CALA Stock Holding History

Jane Street’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,001	Closed	-$67K	–	11429
2021 Q4	$67K	Buy	+5,001	New	+$126K	﹤0.01%	9418
2021 Q3	–	Sell	-3,553	Closed	-$149K	–	11131
2021 Q2	$149K	Buy	3,553 +1,938	+120%	+$85.2K	﹤0.01%	9052
2021 Q1	$79K	Buy	+1,615	New	+$94K	﹤0.01%	8717
2020 Q4	–	Sell	-753	Closed	-$66K	–	8388
2020 Q3	$52K	Buy	+753	New	+$65.7K	﹤0.01%	6909
2020 Q1	–	Sell	-3,414	Closed	-$390K	–	6239
2019 Q4	$390K	Sell	3,414 -645	-16%	-$48.5K	﹤0.01%	3981
2019 Q3	$251K	Buy	+4,059	New	+$325K	﹤0.01%	4371
2018 Q1	–	Sell	-619	Closed	-$103K	–	5631
2017 Q4	$103K	Buy	+619	New	+$159K	﹤0.01%	4343
2017 Q2	–	Sell	-961	Closed	-$222K	–	5045
2017 Q1	$222K	Buy	+961	New	+$166K	﹤0.01%	3758

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Jane Street's CALA Position: Q1 2022 in Review

Jane Street sold out of Calithera Biosciences, Inc (CALA) in Q1 2022, closing a stake of 5,001 shares — an estimated $67K sold.

Jane Street first reported a position in CALA in Q1 2017 and held it in 8 quarters. The position peaked at $390K in Q4 2019. 54 funds tracked by Wall St. Rank hold CALA as of Q1 2022.

Jane Street reported no remaining Calithera Biosciences, Inc position as of Q1 2022 after selling out during the quarter.
Jane Street sold 5,001 Calithera Biosciences, Inc shares in Q1 2022, an estimated $67K.
Jane Street first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 8 quarters.
Jane Street's Calithera Biosciences, Inc position peaked at $390K in Q4 2019.
54 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.